0069-1751 : Talzenna .75 mg Oral Capsule


NDC: 0069-1751
Labeler: Pfizer Laboratories Div Pfizer Inc
Product Type: Human Prescription Drug
Drug Name:  Talzenna
Dosage Form: Oral Capsule
Application #: NDA211651
Rev. Date: 


NDC Package Codes:

  • 0069-1751-30: 1 BOTTLE IN 1 CARTON (0069‑1751‑30) > 30 CAPSULE IN 1 BOTTLE

Active Ingredients:

  • Talazoparib Tosylate

Dosage Strength:

  • .75 mg

Pharmaceutical Classes:

  • Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
  • Poly(ADP-Ribose) Polymerase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0069-0296 Talzenna .25 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-1031 Talzenna .1 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-1195 Talzenna 1 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-1235 Talzenna .35 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 0069-1501 Talzenna .5 mg Oral Capsule by Pfizer Laboratories Div Pfizer Inc
  • 63539-051 Talzenna .5 mg Oral Capsule by U.S. Pharmaceuticals
  • 63539-295 Talzenna 1 mg Oral Capsule by U.S. Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0069-1751 QR Code

< Prev: 0069-1558Next: 0069-1802 >

Related Discussions:

How many people in USA using Sorafenib Tosylate?
Hi, Does anyone know how many people take this medicine in USA? How about its effect? How mean generally how long it can... 2 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.